What is the appropriate dosing of Pepto‑Bismol (bismuth subsalicylate) for children of different age groups?

Pepto-Bismol (Bismuth Subsalicylate) Should Not Be Used in Children Under 12 Years of Age

The FDA-approved dosing for Pepto-Bismol explicitly states it is only for adults and children 12 years and over, and children under 12 years should ask a doctor before use 1. This is the definitive guidance that must be followed in clinical practice.

FDA-Approved Dosing for Ages ≥12 Years

For children 12 years and older and adults 1:

• Diarrhea: 2 tablets (1 dose) every ½ hour OR 4 tablets (2 doses) every hour as needed
• Upset stomach/heartburn/indigestion/nausea: 2 tablets (1 dose) every ½ hour as needed
• Maximum: Do not exceed 8 doses (16 tablets) in 24 hours
• Duration: Use until diarrhea stops but not more than 2 days
• Each tablet contains 262 mg bismuth subsalicylate 1

Critical Safety Concerns in Children <12 Years

The primary concern is Reye's syndrome risk. Bismuth subsalicylate contains salicylate, which is contraindicated in children with viral illnesses due to the association with Reye's syndrome 2. Since viral infections (particularly rotavirus) are common causes of pediatric diarrhea, this creates substantial risk.

Why Research Dosing Cannot Be Applied Clinically

While older research studies used bismuth subsalicylate in children as young as 4 months at doses of 100 mg/kg/day divided into multiple doses 3, 4, these were controlled research settings with close monitoring of salicylate and bismuth levels. The studies showed:

• Modest reduction in diarrhea duration (approximately 1-2 days shorter hospital stay) 4
• No prevention of persistent diarrhea 5
• Blood levels remained below toxic thresholds in monitored settings 3, 4

However, these research protocols are not translatable to real-world practice because:

1. Parents cannot monitor serum salicylate levels at home
2. Viral vs. bacterial etiology is often unknown when treatment begins
3. The risk-benefit ratio does not favor use when oral rehydration therapy is highly effective
4. Chronic use can lead to salicylate toxicity even in adults 6

Recommended Approach for Children <12 Years

For acute diarrhea in children under 12 years:

• Use oral rehydration solution as first-line therapy
• Early refeeding with age-appropriate foods
• Do NOT use bismuth subsalicylate without explicit physician guidance
• If a physician determines use is necessary in a specific clinical scenario, they must:
  • Confirm bacterial (not viral) etiology
  • Calculate weight-based dosing (research used 100 mg/kg/day divided into 4-5 doses)
  • Monitor for salicylate toxicity
  • Limit duration to 5 days maximum

The safest clinical recommendation is to avoid bismuth subsalicylate entirely in children under 12 years and use evidence-based oral rehydration therapy instead.